BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 9200644)

  • 1. Fatty acids mediate the acute extrahepatic effects of insulin on hepatic glucose production in humans.
    Lewis GF; Vranic M; Harley P; Giacca A
    Diabetes; 1997 Jul; 46(7):1111-9. PubMed ID: 9200644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic glucose production is regulated both by direct hepatic and extrahepatic effects of insulin in humans.
    Lewis GF; Zinman B; Groenewoud Y; Vranic M; Giacca A
    Diabetes; 1996 Apr; 45(4):454-62. PubMed ID: 8603767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of free fatty acids and glucagon in the peripheral effect of insulin on glucose production in humans.
    Lewis GF; Vranic M; Giacca A
    Am J Physiol; 1998 Jul; 275(1):E177-86. PubMed ID: 9688888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of different free fatty acids on insulin resistance in rats.
    Han P; Zhang YY; Lu Y; He B; Zhang W; Xia F
    Hepatobiliary Pancreat Dis Int; 2008 Feb; 7(1):91-6. PubMed ID: 18234646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance to insulin's acute direct hepatic effect in suppressing steady-state glucose production in individuals with type 2 diabetes.
    Lewis GF; Carpentier A; Vranic M; Giacca A
    Diabetes; 1999 Mar; 48(3):570-6. PubMed ID: 10078558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of hepatic insulin action in obese type 2 diabetic patients.
    Staehr P; Hother-Nielsen O; Levin K; Holst JJ; Beck-Nielsen H
    Diabetes; 2001 Jun; 50(6):1363-70. PubMed ID: 11375337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucagon enhances the direct suppressive effect of insulin on hepatic glucose production in humans.
    Lewis GF; Vranic M; Giacca A
    Am J Physiol; 1997 Mar; 272(3 Pt 1):E371-8. PubMed ID: 9124541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of fatty acids and ketone bodies on basal insulin secretion in type 2 diabetes.
    Boden G; Chen X
    Diabetes; 1999 Mar; 48(3):577-83. PubMed ID: 10078559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Counterregulatory response to hypoglycemia differs according to the insulin delivery route, but does not affect glucose production in normal humans.
    Lewis GF; Carpentier A; Bilinski D; Giacca A; Vranic M
    J Clin Endocrinol Metab; 1999 Mar; 84(3):1037-46. PubMed ID: 10084592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic physiologic hyperinsulinemia impairs suppression of plasma free fatty acids and increases de novo lipogenesis but does not cause dyslipidemia in conscious normal rats.
    Koopmans SJ; Kushwaha RS; DeFronzo RA
    Metabolism; 1999 Mar; 48(3):330-7. PubMed ID: 10094109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Free fatty acid as a link in the regulation of hepatic glucose output by peripheral insulin.
    Rebrin K; Steil GM; Getty L; Bergman RN
    Diabetes; 1995 Sep; 44(9):1038-45. PubMed ID: 7657026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of muscle and liver to glucose-fatty acid cycle in humans.
    Saloranta C; Koivisto V; Widén E; Falholt K; DeFronzo RA; Härkönen M; Groop L
    Am J Physiol; 1993 Apr; 264(4 Pt 1):E599-605. PubMed ID: 8476039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction between free fatty acids and insulin in the acute control of very low density lipoprotein production in humans.
    Lewis GF; Uffelman KD; Szeto LW; Weller B; Steiner G
    J Clin Invest; 1995 Jan; 95(1):158-66. PubMed ID: 7814610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of free fatty acids and glucose on splanchnic insulin dynamics.
    Hennes MM; Dua A; Kissebah AH
    Diabetes; 1997 Jan; 46(1):57-62. PubMed ID: 8971082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of endogenous glucose production by mild hyperinsulinemia during exercise is determined predominantly by portal venous insulin.
    Camacho RC; Pencek RR; Lacy DB; James FD; Wasserman DH
    Diabetes; 2004 Feb; 53(2):285-93. PubMed ID: 14747277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new method for comparing portal and peripheral venous insulin delivery in humans: tolbutamide versus insulin infusion.
    Lewis GF; Steiner G; Polonsky KS; Weller B; Zinman B
    J Clin Endocrinol Metab; 1994 Jul; 79(1):66-70. PubMed ID: 8027255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a 48-h fat infusion on insulin secretion and glucose utilization.
    Boden G; Chen X; Rosner J; Barton M
    Diabetes; 1995 Oct; 44(10):1239-42. PubMed ID: 7556964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged elevation of plasma free fatty acids desensitizes the insulin secretory response to glucose in vivo in rats.
    Mason TM; Goh T; Tchipashvili V; Sandhu H; Gupta N; Lewis GF; Giacca A
    Diabetes; 1999 Mar; 48(3):524-30. PubMed ID: 10078552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating fatty acids are essential for efficient glucose-stimulated insulin secretion after prolonged fasting in humans.
    Dobbins RL; Chester MW; Daniels MB; McGarry JD; Stein DT
    Diabetes; 1998 Oct; 47(10):1613-8. PubMed ID: 9753300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Free fatty acids impair hepatic insulin extraction in vivo.
    Wiesenthal SR; Sandhu H; McCall RH; Tchipashvili V; Yoshii H; Polonsky K; Shi ZQ; Lewis GF; Mari A; Giacca A
    Diabetes; 1999 Apr; 48(4):766-74. PubMed ID: 10102693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.